Neil Barman

Neil Barman is a physician-executive and the Chief Executive Officer of Sound Blade Medical, a Halifax-based startup building handheld histotripsy devices that use focused ultrasound to liquify tissue without heat or incisions. A Stanford- and Northwestern-trained M.D., he has spent more than two decades turning early medical-device science into approved therapies, including a pivotal role in the first FDA approval of ultrasound renal denervation at ReCor Medical and early roles at companies later acquired by Medtronic and Stryker. He stepped up from COO to CEO at Sound Blade in July 2025 to steer its non-invasive surgery platform through clinical development.